Skip to content

Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa

Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05414097
Acronym
FIND
Enrollment
348
Registered
2022-06-10
Start date
2022-07-16
Completion date
2023-10-20
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

sequential mixed-methods, HIV, screening

Brief summary

The primary aim of the study explore drivers of cervical cancer screening and barriers contributing to low screening coverage among women in South Africa. Secondary aims are determining preferences for cervical cancer prevention services using a discrete choice experiment and developing a multi-level package of interventions that will address barriers to cervical cancer screening and improve engagement in care among women.

Detailed description

Cervical cancer is a leading cause of cancer death among South African women. Despite a comprehensive national cancer control policy, cervical screening coverage is low and attrition during on-ward referrals for diagnostic confirmation and treatment remains common. This study uses a sequential mixed-methods design: Phase 1) A qualitative exploratory phase using focus groups and in-depth interviews with women, men, other stakeholders will inform our design and interpretation of quantitative findings from a multi-cohort DCE. Phase 2) Women will be recruited to participate in the DCE and determine their preferences for cancer screening services. Phase 3) Design Thinking to co-create an intervention package for cervical cancer screening and enhanced linkage between screening, diagnosis, and treatment will be created.

Interventions

OTHERSemi-structured focus group discussions - Women

Semi-structured focus group discussions to explore women's experiences with cervical cancer screening and treatment.

OTHERsemi-structured focus groups discussions - Men

Semi-structured focus group discussions to explore partner dynamics related to women's ability to access cancer screening.

OTHERIn-depth key stakeholders interviews

In-depth interviews to contextualise findings from women and men focus group discussions.

OTHERDiscrete Choice Experiment - Women

Discrete Choice Experiment to determine preferences to different cancer screening models.

OTHERDevelopment and User Pre-testing Workshops

Development and User Pre-testing Workshops to explore acceptability and feasibility of proposed interventions designed using findings from Phases 1 &2.

Sponsors

Fogarty International Center of the National Institute of Health
CollaboratorNIH
UNC Lineberger Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Focus Groups with HIV-positive Women 1. HIV-positive 2. Women 18 years and older 3. Participants should be willing and able to provide written informed consent Focus Groups with HIV-negative Women 1. HIV-negative 2. Women 18 years and older 3. Participants should be willing and able to provide written informed consent Focus Groups with Men 1. Male partners who are 18 years and older 2. Participants should be willing and able to provide written informed consent In-depth Interviews with Key Stakeholders 1. Healthcare providers working within the public health system and other key stakeholders 2. Individuals 18 years and older 3. Participants should be willing and able to provide written informed consent

Exclusion criteria

Focus Groups with HIV-positive Women 1. Women younger than 18 years 2. Unwilling or unable to provide written informed consent Focus Groups with HIV-negative Women 1. Women younger than 18 years 2. Unwilling or unable to provide written informed consent Focus Groups with Men 1. Male partners younger than 18 years 2. Participants unwilling or unable to provide written informed consent In-depth Interviews with Key Stakeholders 1. Providers who do not work in the public health system 2. Individuals younger than 18 years 3. Participants unwilling or unable to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Phase 1: Barriers to cancer screening and engagementSingle visitBarriers and enablers will be explored through focus groups and in-depth interviews with women, men, and other stakeholders.

Secondary

MeasureTime frameDescription
Phase 2: Woman preferences for cancer screening servicesSingle visitPreferences for cancer screening will be determined through the relative importance of the attribute according on how it is scored in the Discrete Choice Experiment.
Phase 3: Acceptability and feasibility of multi-level package of interventions addressing barriers to cancer screening.Single visitAcceptability and feasibility will be measured through development and user pre-testing workshops.

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026